— Know what they know.
Not Investment Advice

BLMS OTC

Bloomios, Inc.
1W: +0.0% 1M: +0.0% 3M: +200.0% YTD: +200.0% 1Y: +200.0% 3Y: -100.0% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Neutral · Power 49 · $19341 mcap · 42M float · 0.0000% daily turnover

Cash Flow Trends

Operating Cash Flow
-$6M -6320.8% ▼
Capital Expenditures
$24K +97.0% ▲
Free Cash Flow
-$6M -608.1% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$339K -271.2% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2018FY2019FY2020FY2021FY2022
— Operating Activities —
Net Income-$10K-$17K-$1M-$2M-$14M
Depreciation & Amort.$0$0$232K$381K$439K
Stock-Based Comp.$0$0$0$277K$531K
Change in Working Capital$0$433K$2M$438K$2M
Other Non-Cash Items$0-$433K$0$1M$4M
Operating Cash Flow-$10K-$17K$821K-$99K-$6M
— Investing Activities —
Capital Expenditures$0$0-$2M-$798K-$24K
Acquisitions (Net)$0$0$0$0-$10M
Investment Purchases$0$0-$350K$0$0
Investment Sales$0$0$0$0$0
Other Investing$0$0-$50K$0$10M
Investing Cash Flow$0$0-$3M-$798K-$24K
— Financing Activities —
Net Debt Issuance$0$0$2M$1M$6M
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$0$0$0$0$0
Financing Cash Flow$10K$17K$2M$1M$6M
Net Change in Cash$0$0$71K$198K-$339K
Cash End of Period$0$0$72K$271K-$69K
Free Cash Flow-$10K-$17K-$1M-$897K-$6M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms